Shuttle Pharmaceuticals | 8-K: Shuttle Pharmicals Receives Notice of Nasdaq's Failure to Satisfy Continued Listing Rules and CEO Anatoly Dritschilo to Attend Emerging Growth Conference on March 6, 2024
Shuttle Pharmaceuticals | 8-K: Shuttle Pharmicals Receives Notice of Nasdaq's Failure to Satisfy Continued Listing Rules and CEO Anatoly Dritschilo to Attend Emerging Growth Conference on March 6, 2024
Shuttle Pharmaceuticals | 8-K：Shuttle Pharmicals收到納斯達克未能滿足繼續上市規則通知及首席執行官Anatoly Dritschilo將出席2024年3月6日新興增長會議